Creative Biolabs provides an antiviral drug discovery service that focuses on the development of research-grade antiviral drugs using novel approaches. We specialize in utilizing viral recombinant protein-based technology to create highly potent antiviral therapeutics. As an integral part of virology research, our service aids scientists in overcoming the challenges presented by viral pandemics.
| Features | Applications |
|
|
Our team of experienced scientists and virologists leverage their expertise in using viral recombinant proteins as a key component for antiviral drug discovery. This high-throughput technology is capable of identifying potential antiviral drugs that are applicable in treating a wide variety of viral pathogens.
We employ cutting-edge techniques to isolate and modify viral proteins, and then use them for drug discovery studies. Using the technologies of gene cloning, protein expression and protein purification, the recombinant viral proteins can be produced efficiently in our specialized laboratories.
We adhere to strict quality control measures, ensuring the production of highly pure and stable recombinant proteins for use in the experimental models. The proteins produced are tested and validated for their biological activity, ensuring the efficiency and accuracy of the drug discovery process.
Understanding that drug discovery studies may require different types of recombinant proteins based on the virus in focus, we offer customized services to meet your specific research needs.
In line with bio-safety standards, we ensure that our laboratories are safely equipped to handle viral recombinant proteins. Our experts understand how to handle these proteins safely and securely.
For more information about Creative Biolabs' viral recombinant protein-based antiviral drug discovery service, please contact our customer service team.
